|

Autologous Hematopoietic Stem cells (HSCs) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Florida1

Indications

  • Progressive Oligodendroglioma1
  • Recurrent Oligodendroglioma1
  • Cancer1

Gainesville, Florida1 trial

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

University of Florida Health Shands Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.